Edit |   |
---|---|
Antigenic Specificity | ALB & CD126, Human (Vobarilizumab biosimilar) |
Clone | Vobarilizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | VH-VH' |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ALB & CD126 Recombinant Antibody. Vobarilizumab (INN, development code ALX0061) is a humanized monoclonal antibody designed for the treatment of inflammatory autoimmune diseases. This drug was developed by Ablynx NV. |
Immunogen | n/a |
Other Names | Anti-ALB & CD126 Recombinant Antibody, Research Grade Vobarilizumab, Anti-Human ALB & CD126 Recombinant Antibody, (20A11-9mer-ALB11), ALX-0061, Antibody Drug Analogues, Monoclonal Antibody, YR1353, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1628814-88-9 |
Catalog # | YR1353 |
Price | please inquire |
Order / More Info | ALB & CD126, Human (Vobarilizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |